Consultation of elexxion AG at recapitalisation and management buy-out


Support of elexxion with a capital increase of  EUR 1.8 mio
The capital increase was part of a complete debt relief from its former main shareholder L-Bank and a sale of all L-Bank shares to the management. It was supported by a new main shareholder.
As a result, elexxion is free of debt capital and is now provided with a liquidity in the amount of EUR 1.8 mio to invest in the further growth of the company.


elexxion AG (Radolfzell) is an innovative medical technology  company specialised on development, production and sale of dental laser systems. The enterprise is listed as Entry Standard at the Frankfurt Stock Exchange.




Max Oppersdorff

Similar Transactions

Subscribe to newsletter

To subscribe to our Newsletter, please use the following link.

© 2019 Quarton, a Cowen Company.